Found: 161
Select item for more details and to access through your institution.
The Hari/Pasquini/Vesole Article Reviewed.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 10, p. 1244
- By:
- Publication type:
- Article
Outcomes of patients with multiple myeloma refractory to standard dose vs low dose lenalidomide.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01039-1
- By:
- Publication type:
- Article
Mode of progression in smoldering multiple myeloma: a study of 406 patients.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-00980-5
- By:
- Publication type:
- Article
Muscle and fat composition in patients with newly diagnosed multiple myeloma.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00934-3
- By:
- Publication type:
- Article
Comparison of daratumumab-based regimens as second-line therapy in relapsed/refractory multiple myeloma.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00957-w
- By:
- Publication type:
- Article
Long-term outcomes of allogeneic stem cell transplant in multiple myeloma.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00900-z
- By:
- Publication type:
- Article
Immunophenotypic and molecular comparison between allogeneic and autologous graft-vs-host disease of the skin: A retrospective study using immunohistochemical and proteomics methods.
- Published in:
- Journal of Cutaneous Pathology, 2017, v. 44, n. 12, p. 1087, doi. 10.1111/cup.13019
- By:
- Publication type:
- Article
Cyclophosphamide Mobilization Does Not Improve Outcome in Patients Receiving Stem Cell Transplantation for Multiple Myeloma.
- Published in:
- Clinical Lymphoma & Myeloma, 2006, v. 6, n. 5, p. 384, doi. 10.3816/clm.2006.n.014
- By:
- Publication type:
- Article
Amyloidosis: Diagnosis and Management.
- Published in:
- Clinical Lymphoma & Myeloma, 2005, v. 6, n. 3, p. 208
- By:
- Publication type:
- Article
Impact of belantamab mafodotin‐induced ocular toxicity on outcomes of patients with advanced multiple myeloma.
- Published in:
- British Journal of Haematology, 2022, v. 199, n. 1, p. 95, doi. 10.1111/bjh.18298
- By:
- Publication type:
- Article
Disease outcomes and biomarkers of progression in smouldering Waldenström macroglobulinaemia.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 2, p. 210, doi. 10.1111/bjh.17691
- By:
- Publication type:
- Article
Implications of detecting serum monoclonal protein by MASS‐fix following stem cell transplantation in multiple myeloma.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 2, p. 380, doi. 10.1111/bjh.17195
- By:
- Publication type:
- Article
Ibrutinib monotherapy outside of clinical trial setting in Waldenström macroglobulinaemia: practice patterns, toxicities and outcomes.
- Published in:
- British Journal of Haematology, 2020, v. 188, n. 3, p. 394, doi. 10.1111/bjh.16168
- By:
- Publication type:
- Article
Ten‐year survivors in AL amyloidosis: characteristics and treatment pattern.
- Published in:
- British Journal of Haematology, 2019, v. 187, n. 5, p. 588, doi. 10.1111/bjh.16096
- By:
- Publication type:
- Article
Clinical features, laboratory characteristics and outcomes of patients with renal versus cardiac light chain amyloidosis.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 4, p. 701, doi. 10.1111/bjh.15832
- By:
- Publication type:
- Article
Substratification of patients with newly diagnosed standard‐risk multiple myeloma.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 2, p. 254, doi. 10.1111/bjh.15800
- By:
- Publication type:
- Article
Impact of duration of induction therapy on survival in newly diagnosed multiple myeloma patients undergoing upfront autologous stem cell transplantation.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 1, p. 71, doi. 10.1111/bjh.15244
- By:
- Publication type:
- Article
Natural history of amyloidosis isolated to fat and bone marrow aspirate.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 1, p. 170, doi. 10.1111/bjh.14205
- By:
- Publication type:
- Article
Dexamethasone, rituximab and cyclophosphamide for relapsed and/or refractory and treatment-naïve patients with Waldenstrom macroglobulinemia.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 1, p. 98, doi. 10.1111/bjh.14826
- By:
- Publication type:
- Article
Elevation of serum lactate dehydrogenase in AL amyloidosis reflects tissue damage and is an adverse prognostic marker in patients not eligible for stem cell transplantation.
- Published in:
- British Journal of Haematology, 2017, v. 178, n. 6, p. 888, doi. 10.1111/bjh.14830
- By:
- Publication type:
- Article
Quantification of clonal circulating plasma cells in relapsed multiple myeloma.
- Published in:
- British Journal of Haematology, 2014, v. 167, n. 4, p. 500, doi. 10.1111/bjh.13067
- By:
- Publication type:
- Article
Natural history, predictors of development of extramedullary disease, and treatment outcomes for patients with extramedullary multiple myeloma.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. 1540, doi. 10.1002/ajh.27023
- By:
- Publication type:
- Article
A phase 1/2 of carfilzomib and melphalan conditioning for autologous stem cell transplantation for multiple myeloma (CARAMEL).
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 8, p. 1277, doi. 10.1002/ajh.26990
- By:
- Publication type:
- Article
Survival trends in young patients with Waldenström macroglobulinemia: Over five decades of experience.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 432, doi. 10.1002/ajh.26807
- By:
- Publication type:
- Article
Thrombosis in multiple myeloma: Risk estimation by induction regimen and association with overall survival.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 413, doi. 10.1002/ajh.26806
- By:
- Publication type:
- Article
Risk factors for severe infection and mortality In patients with COVID‐19 in patients with multiple myeloma and AL amyloidosis.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 1, p. 49, doi. 10.1002/ajh.26762
- By:
- Publication type:
- Article
Multicentric Castleman disease: A single center experience of treatment with a focus on autologous stem cell transplantation.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 4, p. 401, doi. 10.1002/ajh.26466
- By:
- Publication type:
- Article
Impact of achieving a complete response to initial therapy of multiple myeloma and predictors of subsequent outcome.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. 267, doi. 10.1002/ajh.26439
- By:
- Publication type:
- Article
Characteristics and risk factors for thrombosis in POEMS syndrome: A retrospective evaluation of 230 patients.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 2, p. 209, doi. 10.1002/ajh.26422
- By:
- Publication type:
- Article
Prognostic significance of acquired 1q22 gain in multiple myeloma.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 1, p. 52, doi. 10.1002/ajh.26391
- By:
- Publication type:
- Article
Venetoclax for the treatment of multiple myeloma: Outcomes outside of clinical trials.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 9, p. 1131, doi. 10.1002/ajh.26269
- By:
- Publication type:
- Article
Comparison of the current renal staging, progression and response criteria to predict renal survival in AL amyloidosis using a Mayo cohort.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 4, p. 446, doi. 10.1002/ajh.26092
- By:
- Publication type:
- Article
Bendamustine and rituximab (BR) versus dexamethasone, rituximab, and cyclophosphamide (DRC) in patients with Waldenström macroglobulinemia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Asymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myeloma and smoldering myeloma. A series of 144 cases and a review of the literature.
- Published in:
- Annals of Hematology, 2011, v. 90, n. 1, p. 101, doi. 10.1007/s00277-010-1028-8
- By:
- Publication type:
- Article
Catheter Ablation for Atrial Arrhythmias in Patients With Cardiac Amyloidosis.
- Published in:
- Journal of Cardiovascular Electrophysiology, 2016, v. 27, n. 10, p. 1167, doi. 10.1111/jce.13046
- By:
- Publication type:
- Article
Synchronous pityriasis lichenoides et varioliformis acuta and lymphoplasmacytic lymphoma: a distinct association.
- Published in:
- International Journal of Dermatology, 2021, v. 60, n. 12, p. 1550, doi. 10.1111/ijd.15636
- By:
- Publication type:
- Article
Use of beta blockers is associated with survival outcome of multiple myeloma patients treated with pomalidomide.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 3, p. 433, doi. 10.1111/ejh.13559
- By:
- Publication type:
- Article
Characterization and prognostic implication of delayed complete response in AL amyloidosis.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 3, p. 354, doi. 10.1111/ejh.13554
- By:
- Publication type:
- Article
c-erbB-2 and p53 expression in fallopian tube carcinoma.
- Published in:
- 1995
- By:
- Publication type:
- journal article
Phase II Studies in Myeloma.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, p. S40
- By:
- Publication type:
- Article
Response to Rituximab in Patients with Type II Cryoglobulinemia.
- Published in:
- Clinical Lymphoma & Myeloma, 2006, v. 7, n. 2, p. 140
- By:
- Publication type:
- Article
Pitfalls in the Diagnosis of Primary Amyloidosis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2010, v. 10, n. 3, p. 177, doi. 10.3816/CLML.2010.n.027
- By:
- Publication type:
- Article
Clinical course and prognosis of non-secretory multiple myeloma.
- Published in:
- European Journal of Haematology, 2015, v. 95, n. 1, p. 57, doi. 10.1111/ejh.12478
- By:
- Publication type:
- Article
Outcomes and treatments of patients with immunoglobulin light chain amyloidosis who progress or relapse postautologous stem cell transplant.
- Published in:
- European Journal of Haematology, 2014, v. 92, n. 6, p. 485, doi. 10.1111/ejh.12282
- By:
- Publication type:
- Article
Outcomes and treatments of patients with immunoglobulin light chain amyloidosis who progress or relapse post autologous stem cell transplant.
- Published in:
- European Journal of Haematology, 2014, v. 92, n. 2, p. 1, doi. 10.1111/ejh.12282
- By:
- Publication type:
- Article
Evaluation of pretransplant factors predicting cardiac dysfunction following high-dose melphalan conditioning and autologous peripheral blood stem cell transplantation.
- Published in:
- European Journal of Haematology, 2012, v. 89, n. 3, p. 228, doi. 10.1111/j.1600-0609.2012.01815.x
- By:
- Publication type:
- Article
Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome.
- Published in:
- European Journal of Haematology, 2008, v. 80, n. 5, p. 397, doi. 10.1111/j.1600-0609.2008.01037.x
- By:
- Publication type:
- Article
Current status of stem cell transplantation for multiple myeloma.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Serum M-spike and transplant outcome in patients with multiple myeloma.
- Published in:
- Cancer Science, 2007, v. 98, n. 7, p. 1035, doi. 10.1111/j.1349-7006.2007.00499.x
- By:
- Publication type:
- Article
In vivo and in silico studies on single versus multiple transplants for multiple myeloma.
- Published in:
- Cancer Science, 2007, v. 98, n. 5, p. 734, doi. 10.1111/j.1349-7006.2007.00450.x
- By:
- Publication type:
- Article